Enhanced oncogenicity of Asian-American human papillomavirus 16 is associated with impaired E2 repression of E6/E7 oncogene transcription

Journal of General Virology

Volumn 85, Issue 6, 2004, Pages 1433-1444

  Ordóñez, Rosa M ^a   Espinosa, Ana María ^a   Sánchez González, Dolores Javier ^b   Armendáriz Borunda, Juan ^c   Berumen, Jaime ^a  

^a PEMEX   (Mexico)

^b Univ del Ejercito y Fuerza Aerea   (Mexico)

^c UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; PROTEIN E6; PROTEIN E7; VIRUS DNA; DNA BINDING PROTEIN; E1 PROTEIN, HUMAN PAPILLOMAVIRUS 16; E2 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; REPRESSOR PROTEIN;

ARTICLE; ASIAN AMERICAN; CANCER INCIDENCE; CANCER RISK; CARCINOGENICITY; CELL LINE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INACTIVATION; EUROPEAN UNION; FEMALE; GENE ACTIVITY; GENE REPRESSION; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC REGULATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IN VIVO STUDY; MAJOR CLINICAL STUDY; MEXICO; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; UTERINE CERVIX CANCER; VIRUS DNA CELL DNA INTERACTION; VIRUS TYPING; WART VIRUS; GENE EXPRESSION REGULATION; GENETICS; PAPILLOMA VIRUS; PATHOGENICITY; PHYSIOLOGY; UTERINE CERVIX TUMOR; VIROLOGY;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRUS;

DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, VIRAL; HUMANS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; REPRESSOR PROTEINS; UTERINE CERVICAL NEOPLASMS;

EID: 18244415256     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.19317-0     Document Type: Article

References (38)

1. Abrio, A., Kurg, R. & Ustav, M. (1996). Transcriptional and replicational activation functions in the bovine papillomavirus type 1 E2 protein are encoded by different structural determinants. J Viral 70, 6169-6179.
2. Alloul, N. & Sherman, L. (1999). The E2 protein of human papillomavirus type 16 is translated from a variety of differentially spliced polycistronic mRNAs. J Gen Virol 80, 29-37.
3. Bechtold, V., Bread, P. & Raj, K. (2003). Human papillomavirus type 16 E2 protein has no effect on transcription from episomal viral DNA. J Virol 77, 2021-2028.
4. Berumen, J., Casas, L., Segura, E., Amezcua, J. & García-Carrancá, A. (1994). Genome amplification of human papillomavirus type 16 and 18 in cervical carcinomas is related to retention of E1/E2 genes. Int J Cancer 56, 640-645.
5. Berumen, J., Unger, E., Casas, L. & Figueroa, P. (1995). Amplification of human papillomavirus types 16 and 18 in invasive cervical cancer. Hum Pathol 26, 676-681.
6. Berumen, J., Ordoñez, R., Lazcano, E. & 7 other authors (2001). Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst 93, 1325-1330.
7. Bohm, S., Wilczynski, S. P., Pfister, H. & Iftner, T. (1993). The predominant mRNA class in HPV16-infected genital neoplasias does not encode the E6 or the E7 protein. Int J Cancer 155, 791-798.
8. Bradford, M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254.
9. Casas, L., Galvan, S., Ordoñez, R., Lopez, N., Guido, M. & Berumen, J. (1999). Asian-American variants of human papillomavirus type 16 have extensive mutations in the E2 gene and are highly amplified in cervical carcinomas. Int J Cancer 83, 449-455.
10. Cullen, A., Reid, R., Campion, M. & Lörincz, A. (1991). Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol 65, 606-612.
11. Desaintes, C., Demeret, C., Goyat, S., Yaniv, M. & Thierry, F. (1997). Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis. EMBO J 16, 504-514.
12. Dodd, J., Paraskevas, M. & Mcnicol, P. (1992). Detection of human papillomavirus 16 transcription in human prostate tissue. J Urol 149, 400-402.
13. Doorbar, J., Parton, A., Hartley, K., Banks, L., Crook, T., Stanley, M. & Crawford, L. (1990). Detection of novel splicing patterns in a HPV16-containing keratinocyte cell line. Virology 178, 254-262.
14. Frattini, M. G., Lim, H. B. & Laimins, L. A. (1996). In vitro synthesis of oncogenic human papillomaviruses requires episomal genomes for differentiation-dependent late expression. Proc Natl Acad Sci U S A 93, 3062-3067.
15. Guido, M., Zamorano, R., Garrido-Guerrero, E., Gariglio, P. & Garcia-Carrancá, A. (1992). Early promoters of genital and cutaneous human papillomaviruses are differentially regulated by the bovine papillomavirus type 1 E2 gene product. J Gen Virol 73, 1395-1400.
16. Halpern, A. & Munger, K. (1995). HPV16 E7: Primary structure and biological properties. In Human Papillomaviruses 1995: a Compilation and Analysis of Nucleic Acid and Amino Acid Sequences, pp. III-58-III-73. Edited by G. Myers, H. Delius, J. Icenogel, H. U. Bernard, C. Baker, A. Halpern & C. Wheeler. Los Alamos, NM: Los Alamos National Laboratory.
17. Kammer, C., Warthorst, U., Torrez-Martínez, N., Wheeler, C. & Pfister, H. (2000). Sequence analysis of the long control region of hurrian papillomavirus type 16 variants and functional consequences for P97 promoter activity. J Gen Virol 81, 1975-1981.
18. Lazcano, E., Moss, S., Alonso De Ruiz, P., Salmeron, J. & Hernandez, M. (1999). Cervical cancer in developing countries: why it is ineffective, the case of Mexico. Arch Med Res 30, 240-250.
19. Myers, G. & Androphy, E. (1995). The E6 protein. In Human Papillomaviruses: a Compilation and Analysis of Nucleic Acid and Amino Acid Sequences, pp. III-47-III-57. Edited by G. Myers, H. Delius, J. Icenogel, H. U. Bernard, C. Baker, A. Halpern & C. Wheeler. Los Alamos, NM: Los Alamos National Laboratory.
20. Norton, P. & Coffin, J. (1985). Bacterial β-galactosidase as a marker of Rous sarcoma virus gene expression and replication. Mol Cell Biol 5, 281-290.
21. Pray, T. & Laimins, L. (1995). Differentiation-dependent expression of E1∧E4 proteins in cell lines maintaining episomes of human papillomavirus type 31b. Virology 206, 679-685.
22. Rohlfs, M., Winkenbach, S., Meyer, S., Rupp, T. & Durst, M. (1991). Viral transcription in human keratinocyte cell lines immortalized by human papillomavirus type-16. Virology 183, 331-342.
23. Romanczuk, H., Thierry, F. & Howley, P. (1990). Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 p97 and type 18 p105 promoters. J Virol 64, 2849-2859.
24. Sanchez-Perez, A. M., Soriano, S., Clarke, R. & Gaston, K. (1997). Disruption of the human papillomavirus type 16 E2 gene protects cervical carcinoma cells from E2F-induced apoptosis. J Gen Virol 78, 3009-3018.
25. Schneider-Maunoury, S., Croissant, O. & Orth, G. (1987). Integration of human papillomavirus type 16 DNA sequences: a possible early event in the progression of genital tumors. J Virol 61, 3295-3298.
26. Schwarz, E., Freese, U. K., Gissmann, L., Mayer, W., Roggenbuck, B., Stremlau, A. & Zur Hausen, H. (1985). Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314, 111-114.
27. Sherman, L. & Alloul, N. (1992). Human papillomavirus type 16 expresses a variety of alternatively spliced mRNAs putatively encoding the E2 protein. Virology 191, 953-959.
28. Sherman, L., Alloul, N., Golan, I., Durst, M. & Baram, A. (1992). Expression and splicing patterns of human papillomavirus type-16 mRNAs in pre-cancerous lesions and carcinomas of the cervix, in human keratinocytes immortalized by HPV 16, and in cell lines established from cervical cancers. Int J Cancer 50, 356-364.
29. Shirasawa, H., Jin, M., Shimizu, K., Akutsu, N., Shino, Y. & Simizu, B. (1994). Transcription-modulatory activity of full-length E6 and E6I proteins of human papillomavirus type 16. Virology 15, 36-42.
30. Stoler, M., Rhodes, C., Whitbeck, A., Wolinsky, S., Chow, L. & Broker, T. (1992). Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum Pathol 123, 117-128.
31. Stoppler, M., Ching, K., Stoppler, H., Clancy, K., Schlegel, R. & Icenogle, J. (1996). Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J Virol 70, 6987-6993.
32. Thummel, C., Boulet, A. & Lipshitz, H. (1988). Vector for Drosophila P-element-mediated transformation and tissue culture transfection. Gene 74, 445-456.
33. Veress, G., Szarka, K., Dong, X., Gergely, L. & Pfister, H. (1999). Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16. J Gen Virol 80, 1035-1043.
34. Webster, K., Parish, J., Pandya, M., Stern, P. L., Clarke, A. R. & Gaston, K. (2000). The human papillomavirus (HPV) 16 E2 protein induces apoptosis in the absence of other HPV proteins and via a p53-dependent pathway. J Biol Chem 275, 87-94.
35. Webster, K., Taylor, A. & Gaston, K. (2001). Oestrogen and progesterone increase the levels of apoptosis induced by the human papillomavirus type 16 E2 and E7 proteins. J Gen Virol 82, 201-213.
36. Wilczynski, S., Pearlman, L. & Walker, J. (1988). Identification of HPV16 early genes retained in cervical carcinomas. Virology 166, 624-627.
37. Xi, L. F., Koutsky, L. A., Galloway, D. A., Kuypers, J., Hughes, J. P., Wheeler, C. M., Holmes, K. K. & Kiviat, N. (1997). Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst 89, 796-802.
38. Yamada, T., Manos, M., Peto, J., Greer, C., Muñoz, N., Bosch, F. & Wheeler, C. (1997). Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 71, 2463-2472.